GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang Wecome Pharmaceutical Co Ltd (SZSE:300878) » Definitions » Cyclically Adjusted PS Ratio

Zhejiang Wecome Pharmaceutical Co (SZSE:300878) Cyclically Adjusted PS Ratio : 3.47 (As of Jun. 17, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Zhejiang Wecome Pharmaceutical Co Cyclically Adjusted PS Ratio?

As of today (2024-06-17), Zhejiang Wecome Pharmaceutical Co's current share price is ¥14.82. Zhejiang Wecome Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 was ¥4.27. Zhejiang Wecome Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is 3.47.

The historical rank and industry rank for Zhejiang Wecome Pharmaceutical Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SZSE:300878' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 3.53   Med: 5.5   Max: 6.37
Current: 3.53

During the past 11 years, Zhejiang Wecome Pharmaceutical Co's highest Cyclically Adjusted PS Ratio was 6.37. The lowest was 3.53. And the median was 5.50.

SZSE:300878's Cyclically Adjusted PS Ratio is ranked better than
61.11% of 504 companies
in the Biotechnology industry
Industry Median: 5.37 vs SZSE:300878: 3.53

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Zhejiang Wecome Pharmaceutical Co's adjusted revenue per share data of for the fiscal year that ended in Dec23 was ¥3.878. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥4.27 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zhejiang Wecome Pharmaceutical Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Zhejiang Wecome Pharmaceutical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Wecome Pharmaceutical Co Cyclically Adjusted PS Ratio Chart

Zhejiang Wecome Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 5.73 5.95

Zhejiang Wecome Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 5.95 -

Competitive Comparison of Zhejiang Wecome Pharmaceutical Co's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Zhejiang Wecome Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Wecome Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhejiang Wecome Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Wecome Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Zhejiang Wecome Pharmaceutical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Zhejiang Wecome Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=14.82/4.27
=3.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Wecome Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Zhejiang Wecome Pharmaceutical Co's adjusted Revenue per Share data for the fiscal year that ended in Dec23 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=3.878/114.7809*114.7809
=3.878

Current CPI (Dec23) = 114.7809.

Zhejiang Wecome Pharmaceutical Co Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201412 0.000 99.000 0.000
201512 1.915 100.600 2.185
201612 2.597 102.600 2.905
201712 3.750 104.500 4.119
201812 5.301 106.500 5.713
201912 5.914 111.200 6.104
202012 5.171 111.500 5.323
202112 4.395 113.108 4.460
202212 3.709 115.116 3.698
202312 3.878 114.781 3.878

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zhejiang Wecome Pharmaceutical Co  (SZSE:300878) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Zhejiang Wecome Pharmaceutical Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Zhejiang Wecome Pharmaceutical Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Wecome Pharmaceutical Co (SZSE:300878) Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Suisong Road, Lishui Economic Development Zone, Zhejiang Province, Lishui, CHN, 323000
Zhejiang Wecome Pharmaceutical Co Ltd is engaged in production and sales of modern Chinese medicine and western medicine. The company produces hard capsules, tablets, granules, soft capsules, pills (dropping pills).
Executives
Dai De Xiong Executives
Liu Zhong Liang Director

Zhejiang Wecome Pharmaceutical Co (SZSE:300878) Headlines

No Headlines